{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:09:20Z","timestamp":1795050560363,"version":"4.10.2"},"reference-count":228,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1038\/s41581-023-00694-0","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T12:02:53Z","timestamp":1679572973000},"page":"281-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":428,"title":["Regulated cell death pathways in kidney disease"],"prefix":"10.1038","volume":"19","author":[{"given":"Ana B.","family":"Sanz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"Sanchez-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian M.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"694_CR1","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392, 2052\u20132090 (2018).","journal-title":"Lancet"},{"key":"694_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/ckj\/sfab170","volume":"15","author":"A Ortiz","year":"2021","unstructured":"Ortiz, A. et al. RICORS2040: the need for collaborative research in chronic kidney disease. Clin. Kidney J. 15, 372\u2013387 (2021).","journal-title":"Clin. Kidney J."},{"key":"694_CR3","unstructured":"Chapman, A. B., Rahbari-Oskoui, F. F & Bennett, W. M. Acquired cystic disease of the kidney in adults. UpToDate https:\/\/www.uptodate.com\/contents\/acquired-cystic-disease-of-the-kidney-in-adults (2023)."},{"key":"694_CR4","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1046\/j.1523-1755.2002.00374.x","volume":"61","author":"MD Denton","year":"2002","unstructured":"Denton, M. D. et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 61, 2201\u20132209 (2002).","journal-title":"Kidney Int."},{"key":"694_CR5","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1097\/PAS.0000000000001530","volume":"44","author":"A Shah","year":"2020","unstructured":"Shah, A. et al. Acquired cystic kidney disease-associated renal cell carcinoma (ACKD-RCC) harbor recurrent mutations in KMT2C and TSC2 genes. Am. J. Surg. Pathol. 44, 1479\u20131486 (2020).","journal-title":"Am. J. Surg. Pathol."},{"key":"694_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 1\u2013150 (2013).","journal-title":"Kidney Int. Suppl."},{"key":"694_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1681\/ASN.2021101293","volume":"33","author":"F Maremonti","year":"2022","unstructured":"Maremonti, F., Meyer, C. & Linkermann, A. Mechanisms and models of kidney tubular necrosis and nephron loss. J. Am. Soc. Nephrol. 33, 472\u2013486 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.kint.2021.03.011","volume":"100","author":"AJ Peired","year":"2021","unstructured":"Peired, A. J., Lazzeri, E., Guzzi, F., Anders, H. J. & Romagnani, P. From kidney injury to kidney cancer. Kidney Int. 100, 55\u201366 (2021).","journal-title":"Kidney Int."},{"key":"694_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla, L. S., Eggers, P. W., Star, R. A. & Kimmel, P. L. Acute kidney injury and chronic kidney disease as interconnected syndromes. N. Engl. J. Med. 371, 58\u201366 (2014).","journal-title":"N. Engl. J. Med."},{"key":"694_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486\u2013541 (2018).","journal-title":"Cell Death Differ."},{"key":"694_CR11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni.3253","volume":"16","author":"S Arandjelovic","year":"2015","unstructured":"Arandjelovic, S. & Ravichandran, K. S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907\u2013917 (2015).","journal-title":"Nat. Immunol."},{"key":"694_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-020-2121-3","volume":"580","author":"CB Medina","year":"2020","unstructured":"Medina, C. B. et al. Metabolites released from apoptotic cells act as tissue messengers. Nature 580, 130\u2013135 (2020).","journal-title":"Nature"},{"key":"694_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41586-018-0735-5","volume":"563","author":"S Morioka","year":"2018","unstructured":"Morioka, S. et al. Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release. Nature 563, 714\u2013718 (2018).","journal-title":"Nature"},{"key":"694_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ki.2011.120","volume":"80","author":"A Havasi","year":"2011","unstructured":"Havasi, A. & Borkan, S. C. Apoptosis and acute kidney injury. Kidney Int. 80, 29\u201340 (2011).","journal-title":"Kidney Int."},{"key":"694_CR15","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1681\/ASN.2007121336","volume":"19","author":"AB Sanz","year":"2008","unstructured":"Sanz, A. B., Santamar\u00eda, B., Ruiz-Ortega, M., Egido, J. & Ortiz, A. Mechanisms of renal apoptosis in health and disease. J. Am. Soc. Nephrol. 19, 1634\u20131642 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR16","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1093\/ndt\/gfs373","volume":"27","author":"A Linkermann","year":"2012","unstructured":"Linkermann, A., De Zen, F., Weinberg, J., Kunzendorf, U. & Krautwald, S. Programmed necrosis in acute kidney injury. Nephrol. Dial. Transpl. 27, 3412\u20133419 (2012).","journal-title":"Nephrol. Dial. Transpl."},{"key":"694_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ki.2011.450","volume":"81","author":"A Linkermann","year":"2012","unstructured":"Linkermann, A. et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia\/reperfusion injury. Kidney Int. 81, 751\u2013761 (2012).","journal-title":"Kidney Int."},{"key":"694_CR18","doi-asserted-by":"publisher","first-page":"12024","DOI":"10.1073\/pnas.1305538110","volume":"110","author":"A Linkermann","year":"2013","unstructured":"Linkermann, A. et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 110, 12024\u201312029 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"694_CR19","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1681\/ASN.2018121218","volume":"30","author":"SR Mulay","year":"2019","unstructured":"Mulay, S. R. et al. Mitochondria permeability transition versus necroptosis in oxalate-induced AKI. J. Am. Soc. Nephrol. 30, 1857\u20131869\u00a0(2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133282","volume":"5","author":"\u00c1 Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez, \u00c1. et al. Interaction between the autophagy protein beclin 1 and Na+,K+-ATPase during starvation, exercise, and ischemia. JCI Insight 5, e133282\u00a0(2020).","journal-title":"JCI Insight"},{"key":"694_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrneph.2016.71","volume":"12","author":"S Gupta","year":"2016","unstructured":"Gupta, S. & Kaplan, M. J. The role of neutrophils and NETosis in autoimmune and renal diseases. Nat. Rev. Nephrol. 12, 402\u2013413 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"694_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood, C. et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22, 146\u2013153 (2016).","journal-title":"Nat. Med."},{"key":"694_CR23","doi-asserted-by":"publisher","first-page":"16836","DOI":"10.1073\/pnas.1415518111","volume":"111","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A. et al. Synchronized renal tubular cell death involves ferroptosis. Proc. Natl Acad. Sci. USA 111, 16836\u201316841 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"694_CR24","doi-asserted-by":"publisher","first-page":"20364","DOI":"10.1073\/pnas.1319661110","volume":"110","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc. Natl Acad. Sci. USA 110, 20364\u201320371 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"694_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines, C. P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658\u2013662 (2005).","journal-title":"Nature"},{"key":"694_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nature03317","volume":"434","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa, T. et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652\u2013658 (2005).","journal-title":"Nature"},{"key":"694_CR27","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1681\/ASN.2014070673","volume":"26","author":"SV Kumar","year":"2015","unstructured":"Kumar, S. V. et al. Neutrophil extracellular trap-related extracellular histones cause vascular necrosis in severe GN. J. Am. Soc. Nephrol. 26, 2399\u20132413 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR28","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.2337\/db22-0153","volume":"71","author":"F Zheng","year":"2022","unstructured":"Zheng, F. et al. Neutrophil extracellular traps induce glomerular endothelial cell dysfunction and pyroptosis in diabetic kidney disease. Diabetes 71, 2739\u20132750\u00a0(2022).","journal-title":"Diabetes"},{"key":"694_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00658-w","author":"B Kolbrink","year":"2023","unstructured":"Kolbrink, B., von Samson-Himmelstjerna, F. A., Murphy, J. M. & Krautwald, S. Role of necroptosis in kidney health and disease. Nat. Rev. Nephrol. https:\/\/doi.org\/10.1038\/s41581-022-00658-w (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"694_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00662-0","author":"EE Elias","year":"2023","unstructured":"Elias, E. E., Lyons, B. & Muruve, D. A. Gasdermins and pyroptosis in the kidney. Nat. Rev. Nephrol. https:\/\/doi.org\/10.1038\/s41581-022-00662-0 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"694_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00689-x","author":"H Bayir","year":"2023","unstructured":"Bayir, H. et al. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat. Rev. Nephrol. https:\/\/doi.org\/10.1038\/s41581-023-00689-x (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"694_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui, S., Herold, M. J. & Strasser, A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat. Rev. Mol. Cell Biol. 21, 678\u2013695 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"694_CR33","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.3390\/ijms23116198","volume":"23","author":"C Ganini","year":"2022","unstructured":"Ganini, C. et al. No time to die: how kidney cancer evades cell death. Int. J. Mol. Sci. 23, 6198\u00a0(2022).","journal-title":"Int. J. Mol. Sci."},{"key":"694_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/356314a0","volume":"356","author":"R Watanabe-Fukunaga","year":"1992","unstructured":"Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. & Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314\u2013317 (1992).","journal-title":"Nature"},{"key":"694_CR35","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","volume":"76","author":"T Takahashi","year":"1994","unstructured":"Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969\u2013976 (1994).","journal-title":"Cell"},{"key":"694_CR36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000490807","volume":"140","author":"A von M\u00e4ssenhausen","year":"2018","unstructured":"von M\u00e4ssenhausen, A., Tonnus, W. & Linkermann, A. Cell death pathways drive necroinflammation during acute kidney injury. Nephron 140, 144\u2013147 (2018).","journal-title":"Nephron"},{"key":"694_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1681\/ASN.2015040405","volume":"27","author":"SR Mulay","year":"2016","unstructured":"Mulay, S. R., Linkermann, A. & Anders, H. J. Necroinflammation in kidney disease. J. Am. Soc. Nephrol. 27, 27\u201339 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR38","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1681\/ASN.2021050690","volume":"32","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Detection of PKD1 and PKD2 somatic variants in autosomal dominant polycystic kidney cyst epithelial cells by whole-genome sequencing. J. Am. Soc. Nephrol. 32, 3114\u20133129 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR39","doi-asserted-by":"publisher","first-page":"eaaw6003","DOI":"10.1126\/scitranslmed.aaw6003","volume":"12","author":"AJ Peired","year":"2020","unstructured":"Peired, A. J. et al. Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells. Sci. Transl Med. 12, eaaw6003\u00a0(2020).","journal-title":"Sci. Transl Med."},{"key":"694_CR40","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1681\/ASN.2017050581","volume":"29","author":"B Yang","year":"2018","unstructured":"Yang, B. et al. Caspase-3 is a pivotal regulator of microvascular rarefaction and renal fibrosis after ischemia-reperfusion injury. J. Am. Soc. Nephrol. 29, 1900\u20131916 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR41","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1172\/JCI135773","volume":"130","author":"YH Chou","year":"2020","unstructured":"Chou, Y. H. et al. Methylation in pericytes after acute injury promotes chronic kidney disease. J. Clin. Invest. 130, 4845\u20134857 (2020).","journal-title":"J. Clin. Invest."},{"key":"694_CR42","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0002-9440(10)61209-6","volume":"167","author":"JS Duffield","year":"2005","unstructured":"Duffield, J. S. et al. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am. J. Pathol. 167, 1207\u20131219 (2005).","journal-title":"Am. J. Pathol."},{"key":"694_CR43","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","volume":"147","author":"Y Fuchs","year":"2011","unstructured":"Fuchs, Y. & Steller, H. Programmed cell death in animal development and disease. Cell 147, 742\u2013758 (2011).","journal-title":"Cell"},{"key":"694_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1681\/ASN.V5112","volume":"5","author":"J Savill","year":"1994","unstructured":"Savill, J. Apoptosis and the kidney. J. Am. Soc. Nephrol. 5, 12\u201321 (1994).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF02915110","volume":"64","author":"A Shimizu","year":"1993","unstructured":"Shimizu, A. & Yamanaka, N. Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 64, 171\u2013180 (1993).","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"694_CR46","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/ki.1997.239","volume":"51","author":"S Gonz\u00e1lez-Cuadrado","year":"1997","unstructured":"Gonz\u00e1lez-Cuadrado, S. et al. Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Kidney Int. 51, 1739\u20131746 (1997).","journal-title":"Kidney Int."},{"key":"694_CR47","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.119.3.493","volume":"119","author":"Y Gavrieli","year":"1992","unstructured":"Gavrieli, Y., Sherman, Y. & Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493\u2013501 (1992).","journal-title":"J. Cell Biol."},{"key":"694_CR48","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/00007890-199510270-00006","volume":"60","author":"H Ito","year":"1995","unstructured":"Ito, H., Kasagi, N., Shomori, K., Osaki, M. & Adachi, H. Apoptosis in the human allografted kidney. Analysis by terminal deoxynucleotidyl transferase-mediated DUTP-botin nick end labeling. Transplantation 60, 794\u2013798 (1995).","journal-title":"Transplantation"},{"key":"694_CR49","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/path.5248","volume":"247","author":"W Tonnus","year":"2019","unstructured":"Tonnus, W. et al. The pathological features of regulated necrosis. J. Pathol. 247, 697\u2013707 (2019).","journal-title":"J. Pathol."},{"key":"694_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ymeth.2013.02.011","volume":"61","author":"T Vanden Berghe","year":"2013","unstructured":"Vanden Berghe, T. et al. Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods 61, 117\u2013129 (2013).","journal-title":"Methods"},{"key":"694_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09397-2","volume":"10","author":"C Rogers","year":"2019","unstructured":"Rogers, C. et al. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat. Commun. 10, 1689 (2019).","journal-title":"Nat. Commun."},{"key":"694_CR52","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41418-022-00977-2","volume":"29","author":"D Moujalled","year":"2022","unstructured":"Moujalled, D. et al. BH3 mimetic drugs cooperate with temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells. Cell Death Differ. 29, 1335\u20131348 (2022).","journal-title":"Cell Death Differ."},{"key":"694_CR53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","volume":"80","author":"T Miyashita","year":"1995","unstructured":"Miyashita, T. & Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293\u2013299 (1995).","journal-title":"Cell"},{"key":"694_CR54","first-page":"3131","volume":"54","author":"T Miyashita","year":"1994","unstructured":"Miyashita, T., Harigai, M., Hanada, M. & Reed, J. C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54, 3131\u20133135 (1994).","journal-title":"Cancer Res."},{"key":"694_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57\u201362 (2015).","journal-title":"Nature"},{"key":"694_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25377-x","volume":"12","author":"Y Guan","year":"2021","unstructured":"Guan, Y. et al. A single genetic locus controls both expression of DPEP1\/CHMP1A and kidney disease development via ferroptosis. Nat. Commun. 12, 5078 (2021).","journal-title":"Nat. Commun."},{"key":"694_CR57","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1681\/ASN.2008111204","volume":"20","author":"BA Molitoris","year":"2009","unstructured":"Molitoris, B. A. et al. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J. Am. Soc. Nephrol. 20, 1754\u20131764 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR58","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1523-1755.2004.761_7.x","volume":"66","author":"PC Dagher","year":"2004","unstructured":"Dagher, P. C. Apoptosis in ischemic renal injury: roles of GTP depletion and p53. Kidney Int. 66, 506\u2013509 (2004).","journal-title":"Kidney Int."},{"key":"694_CR59","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03510897 (2021)."},{"key":"694_CR60","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1161\/CIRCULATIONAHA.120.053029","volume":"144","author":"M Thielmann","year":"2021","unstructured":"Thielmann, M. et al. Teprasiran, a small interfering RNA, for the prevention of acute kidney injury in high-risk patients undergoing cardiac surgery: a randomized clinical study. Circulation 144, 1133\u20131144 (2021).","journal-title":"Circulation"},{"key":"694_CR61","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nri3743","volume":"14","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A., Stockwell, B. R., Krautwald, S. & Anders, H. J. Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat. Rev. Immunol. 14, 759\u2013767 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"694_CR62","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2017.03.020","volume":"169","author":"YN Gong","year":"2017","unstructured":"Gong, Y. N. et al. ESCRT-III acts downstream of MLKL to regulate necroptotic. Cell 169, 286\u2013300.e16 (2017).","journal-title":"Cell"},{"key":"694_CR63","doi-asserted-by":"publisher","first-page":"eabn5881","DOI":"10.1126\/scisignal.abn5881","volume":"15","author":"W Zhang","year":"2022","unstructured":"Zhang, W., Fan, W., Guo, J. & Wang, X. Osmotic stress activates RIPK3\/MLKL-mediated necroptosis by increasing cytosolic pH through a plasma membrane Na+\/H+ exchanger. Sci. Signal. 15, eabn5881 (2022).","journal-title":"Sci. Signal."},{"key":"694_CR64","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41581-022-00607-7","volume":"18","author":"A Ortiz","year":"2022","unstructured":"Ortiz, A. & Sanz, A. B. A pathway of osmotic stress-induced necroptosis. Nat. Rev. Nephrol. 18, 609\u2013610 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"694_CR65","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1681\/ASN.2021030383","volume":"33","author":"D Martin-Sanchez","year":"2022","unstructured":"Martin-Sanchez, D. et al. Bone marrow-derived RIPK3 mediates kidney inflammation in acute kidney injury. J. Am. Soc. Nephrol. 33, 357\u2013373 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2022.12.009","author":"J Guerrero-Mauvecin","year":"2022","unstructured":"Guerrero-Mauvecin, J. et al. RIPK3 and kidney disease. Nefrologia https:\/\/doi.org\/10.1016\/j.nefro.2022.12.009 (2022).","journal-title":"Nefrologia"},{"key":"694_CR67","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1038\/sj.ki.5001866","volume":"70","author":"P Justo","year":"2006","unstructured":"Justo, P. et al. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int. 70, 1750\u20131758 (2006).","journal-title":"Kidney Int."},{"key":"694_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/cdd.2012.151","volume":"20","author":"P Vandenabeele","year":"2013","unstructured":"Vandenabeele, P., Grootjans, S., Callewaert, N. & Takahashi, N. Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models. Cell Death Differ. 20, 185\u2013187 (2013).","journal-title":"Cell Death Differ."},{"key":"694_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.176","volume":"3","author":"N Takahashi","year":"2012","unstructured":"Takahashi, N. et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 3, e437 (2012).","journal-title":"Cell Death Dis."},{"key":"694_CR70","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191 (2014).","journal-title":"Nat. Cell Biol."},{"key":"694_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24712-6","volume":"12","author":"W Tonnus","year":"2021","unstructured":"Tonnus, W. et al. Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury. Nat. Commun. 12, 4402 (2021).","journal-title":"Nat. Commun."},{"key":"694_CR72","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","volume":"56","author":"P Mandal","year":"2014","unstructured":"Mandal, P. et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56, 481\u2013495 (2014).","journal-title":"Mol. Cell"},{"key":"694_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00564-w","author":"P Vandenabeele","year":"2022","unstructured":"Vandenabeele, P., Bultynck, G. & Savvides, S. N. Pore-forming proteins as drivers of membrane permeabilization in cell death pathways. Nat. Rev. Mol. Cell Biol. https:\/\/doi.org\/10.1038\/s41580-022-00564-w (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"694_CR74","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.abi5934","volume":"374","author":"K Newton","year":"2021","unstructured":"Newton, K., Dixit, V. M. & Kayagaki, N. Dying cells fan the flames of inflammation. Science 374, 1076\u20131080 (2021).","journal-title":"Science"},{"key":"694_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111\u2013116 (2016).","journal-title":"Nature"},{"key":"694_CR76","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660\u2013665 (2015).","journal-title":"Nature"},{"key":"694_CR77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.immuni.2017.11.013","volume":"48","author":"CL Evavold","year":"2018","unstructured":"Evavold, C. L. et al. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity 48, 35\u201344.e6 (2018).","journal-title":"Immunity"},{"key":"694_CR78","doi-asserted-by":"publisher","first-page":"167427","DOI":"10.1016\/j.jmb.2021.167427","volume":"434","author":"A Cao","year":"2022","unstructured":"Cao, A. & Kagan, J. C. Gasdermin pore forming activities that promote inflammation from living and dead cells. J. Mol. Biol. 434, 167427 (2022).","journal-title":"J. Mol. Biol."},{"key":"694_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27692-9","volume":"13","author":"AB Santa Cruz Garcia","year":"2022","unstructured":"Santa Cruz Garcia, A. B., Schnur, K. P., Malik, A. B. & Mo, G. C. H. Gasdermin D pores are dynamically regulated by local phosphoinositide circuitry. Nat. Commun. 13, 52 (2022).","journal-title":"Nat. Commun."},{"key":"694_CR80","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78609","volume":"11","author":"JP Borges","year":"2022","unstructured":"Borges, J. P. et al. Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. eLife 11, e78609\u00a0(2022).","journal-title":"eLife"},{"key":"694_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14128","volume":"8","author":"C Rogers","year":"2017","unstructured":"Rogers, C. et al. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death. Nat. Commun. 8, 14128 (2017).","journal-title":"Nat. Commun."},{"key":"694_CR82","doi-asserted-by":"publisher","first-page":"eaar6676","DOI":"10.1126\/sciimmunol.aar6676","volume":"3","author":"KW Chen","year":"2018","unstructured":"Chen, K. W. et al. Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps. Sci. Immunol. 3, eaar6676\u00a0(2018).","journal-title":"Sci. Immunol."},{"key":"694_CR83","doi-asserted-by":"publisher","first-page":"eaar6689","DOI":"10.1126\/sciimmunol.aar6689","volume":"3","author":"G Sollberger","year":"2018","unstructured":"Sollberger, G. et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci. Immunol. 3, eaar6689\u00a0(2018).","journal-title":"Sci. Immunol."},{"key":"694_CR84","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/JCI63679","volume":"123","author":"SR Mulay","year":"2013","unstructured":"Mulay, S. R. et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1\u03b2 secretion. J. Clin. Invest. 123, 236\u2013246 (2013).","journal-title":"J. Clin. Invest."},{"key":"694_CR85","doi-asserted-by":"publisher","first-page":"108998","DOI":"10.1016\/j.celrep.2021.108998","volume":"35","author":"B Zhou","year":"2021","unstructured":"Zhou, B. & Abbott, D. W. Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases. Cell Rep. 35, 108998 (2021).","journal-title":"Cell Rep."},{"key":"694_CR86","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"694_CR87","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.nefro.2020.03.005","volume":"40","author":"D Martin-Sanchez","year":"2020","unstructured":"Martin-Sanchez, D. et al. Ferroptosis and kidney disease. Nefrologia 40, 384\u2013394 (2020).","journal-title":"Nefrologia"},{"key":"694_CR88","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41556-020-0565-1","volume":"22","author":"M Riegman","year":"2020","unstructured":"Riegman, M. et al. Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture. Nat. Cell Biol. 22, 1042\u20131048 (2020).","journal-title":"Nat. Cell Biol."},{"key":"694_CR89","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41556-020-0564-2","volume":"22","author":"A Katikaneni","year":"2020","unstructured":"Katikaneni, A. et al. Lipid peroxidation regulates long-range wound detection through 5-lipoxygenase in zebrafish. Nat. Cell Biol. 22, 1049\u20131055 (2020).","journal-title":"Nat. Cell Biol."},{"key":"694_CR90","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.4049\/jimmunol.2200508","volume":"209","author":"N Pandian","year":"2022","unstructured":"Pandian, N. & Kanneganti, T. D. PANoptosis: a unique innate immune inflammatory cell death modality. J. Immunol. 209, 1625\u20131633 (2022).","journal-title":"J. Immunol."},{"key":"694_CR91","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cell.2020.03.040","volume":"181","author":"M Zheng","year":"2020","unstructured":"Zheng, M., Karki, R., Vogel, P. & Kanneganti, T. D. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell 181, 674\u2013687.e13 (2020).","journal-title":"Cell"},{"key":"694_CR92","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3892\/ijmm.2012.1139","volume":"30","author":"MH Lee","year":"2012","unstructured":"Lee, M. H., Choi, E. N., Jeon, Y. J. & Jung, S. C. Possible role of transforming growth factor-\u03b21 and vascular endothelial growth factor in Fabry disease nephropathy. Int. J. Mol. Med. 30, 1275\u20131280 (2012).","journal-title":"Int. J. Mol. Med."},{"key":"694_CR93","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1046\/j.1523-1755.2002.00427.x","volume":"62","author":"AB Singh","year":"2002","unstructured":"Singh, A. B., Kaushal, V., Megyesi, J. K., Shah, S. V. & Kaushal, G. P. Cloning and expression of rat caspase-6 and its localization in renal ischemia\/reperfusion injury. Kidney Int. 62, 106\u2013115 (2002).","journal-title":"Kidney Int."},{"key":"694_CR94","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/S0006-2952(03)00515-X","volume":"66","author":"A Ortiz","year":"2003","unstructured":"Ortiz, A., Justo, P., Sanz, A., Lorz, C. & Egido, J. Targeting apoptosis in acute tubular injury. Biochem. Pharmacol. 66, 1589\u20131594 (2003).","journal-title":"Biochem. Pharmacol."},{"key":"694_CR95","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1007\/s00018-017-2547-4","volume":"74","author":"T M\u00fcller","year":"2017","unstructured":"M\u00fcller, T. et al. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure. Cell Mol. Life Sci. 74, 3631\u20133645 (2017).","journal-title":"Cell Mol. Life Sci."},{"key":"694_CR96","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1073\/pnas.1716578115","volume":"115","author":"D Martin-Sanchez","year":"2018","unstructured":"Martin-Sanchez, D. et al. TWEAK and RIPK1 mediate a second wave of cell death during AKI. Proc. Natl Acad. Sci. USA 115, 4182\u20134187 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"694_CR97","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41418-020-00691-x","volume":"28","author":"L Pedrera","year":"2021","unstructured":"Pedrera, L. et al. Ferroptotic pores induce Ca2+ fluxes and ESCRT-III activation to modulate cell death kinetics. Cell Death Differ. 28, 1644\u20131657 (2021).","journal-title":"Cell Death Differ."},{"key":"694_CR98","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.aar7607","volume":"362","author":"S R\u00fchl","year":"2018","unstructured":"R\u00fchl, S. et al. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science 362, 956\u2013960 (2018).","journal-title":"Science"},{"key":"694_CR99","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-021-03218-7","volume":"591","author":"N Kayagaki","year":"2021","unstructured":"Kayagaki, N. et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 591, 131\u2013136 (2021).","journal-title":"Nature"},{"key":"694_CR100","doi-asserted-by":"crossref","unstructured":"Hirata Y, et al. Lipid peroxidation increases membrane tension, Piezo1 gating and cation permeability to execute ferroptosis. Preprint at bioRxiv https:\/\/biorxiv.org\/content\/10.1101\/2022.10.31.514557v1 (2022).","DOI":"10.1101\/2022.10.31.514557"},{"key":"694_CR101","doi-asserted-by":"publisher","first-page":"E9618","DOI":"10.1073\/pnas.1708247114","volume":"114","author":"A Schreiber","year":"2017","unstructured":"Schreiber, A. et al. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis. Proc. Natl Acad. Sci. USA 114, E9618\u2013E9625 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"694_CR102","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154277","volume":"23","author":"D Chauhan","year":"2022","unstructured":"Chauhan, D. et al. GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis. EMBO Rep. 23, e54277 (2022).","journal-title":"EMBO Rep."},{"key":"694_CR103","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/ASN.2015121376","volume":"28","author":"D Martin-Sanchez","year":"2017","unstructured":"Martin-Sanchez, D. et al. Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI. J. Am. Soc. Nephrol. 28, 218\u2013229 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR104","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/08860229009087124","volume":"12","author":"U Metz-Kurschel","year":"1990","unstructured":"Metz-Kurschel, U. et al. Folate nephropathy occurring during cytotoxic chemotherapy with high-dose folinic acid and 5-fluorouracil. Ren. Fail. 12, 93\u201397 (1990).","journal-title":"Ren. Fail."},{"key":"694_CR105","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00005792-198905000-00005","volume":"68","author":"S Olsen","year":"1989","unstructured":"Olsen, S. et al. Primary acute renal failure (\u201cacute tubular necrosis\u201d) in the transplanted kidney: morphology and pathogenesis. Medicine 68, 173\u2013187 (1989).","journal-title":"Medicine"},{"key":"694_CR106","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1681\/ASN.2012121169","volume":"24","author":"A Linkermann","year":"2013","unstructured":"Linkermann, A. et al. The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice. J. Am. Soc. Nephrol. 24, 1545\u20131557 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR107","doi-asserted-by":"publisher","first-page":"F1259","DOI":"10.1152\/ajprenal.00311.2014","volume":"308","author":"E Homsi","year":"2015","unstructured":"Homsi, E., Andreazzi, D. D., Faria, J. B. & Janino, P. TNF-\u03b1-mediated cardiorenal injury after rhabdomyolysis in rats. Am. J. Physiol. Ren. Physiol. 308, F1259\u2013F1267 (2015).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"694_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10274","volume":"7","author":"SR Mulay","year":"2016","unstructured":"Mulay, S. R. et al. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat. Commun. 7, 10274 (2016).","journal-title":"Nat. Commun."},{"key":"694_CR109","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1681\/ASN.2014080741","volume":"26","author":"Y Xu","year":"2015","unstructured":"Xu, Y. et al. A role for tubular necroptosis in cisplatin-induced AKI. J. Am. Soc. Nephrol. 26, 2647\u20132658 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR110","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000478746","volume":"46","author":"X Xiao","year":"2017","unstructured":"Xiao, X. et al. Inhibition of necroptosis attenuates kidney inflammation and interstitial fibrosis induced by unilateral ureteral obstruction. Am. J. Nephrol. 46, 131\u2013138 (2017).","journal-title":"Am. J. Nephrol."},{"key":"694_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156729","volume":"11","author":"Y Zhu","year":"2016","unstructured":"Zhu, Y., Cui, H., Xia, Y. & Gan, H. RIPK3-mediated necroptosis and apoptosis contributes to renal tubular cell progressive loss and chronic kidney disease progression in rats. PLoS ONE 11, e0156729 (2016).","journal-title":"PLoS ONE"},{"key":"694_CR112","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200163R","volume":"36","author":"BF Hu","year":"2022","unstructured":"Hu, B. F. et al. Protective effect of inhibiting necroptosis on gentamicin-induced nephrotoxicity. FASEB J. 36, e22487 (2022).","journal-title":"FASEB J."},{"key":"694_CR113","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/j.jaut.2019.05.014","volume":"103","author":"C Guo","year":"2019","unstructured":"Guo, C. et al. Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation. J. Autoimmun. 103, 102286 (2019).","journal-title":"J. Autoimmun."},{"key":"694_CR114","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98411","volume":"3","author":"A Sureshbabu","year":"2018","unstructured":"Sureshbabu, A. et al. RIPK3 promotes sepsis-induced acute kidney injury via mitochondrial dysfunction. JCI Insight 3, e98411\u00a0(2018).","journal-title":"JCI Insight"},{"key":"694_CR115","first-page":"1613","volume":"20","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. RIPK3 mediates renal tubular epithelial cell apoptosis in endotoxin-induced acute kidney injury. Mol. Med. Rep. 20, 1613\u20131620 (2019).","journal-title":"Mol. Med. Rep."},{"key":"694_CR116","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94979","volume":"3","author":"M Imamura","year":"2018","unstructured":"Imamura, M. et al. RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase. JCI Insight 3, e98411\u00a0(2018).","journal-title":"JCI Insight"},{"key":"694_CR117","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","volume":"171","author":"SE Wenzel","year":"2017","unstructured":"Wenzel, S. E. et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell 171, 628\u2013641.e6 (2017).","journal-title":"Cell"},{"key":"694_CR118","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1096\/fj.201900077R","volume":"33","author":"M Guerrero-Hue","year":"2019","unstructured":"Guerrero-Hue, M. et al. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. FASEB J. 33, 8961\u20138975 (2019).","journal-title":"FASEB J."},{"key":"694_CR119","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3892\/ijmm.2020.4770","volume":"47","author":"Z He","year":"2021","unstructured":"He, Z. et al. Role of ferroptosis induced by a high concentration of calcium oxalate in the formation and development of urolithiasis. Int. J. Mol. Med. 47, 289\u2013301 (2021).","journal-title":"Int. J. Mol. Med."},{"key":"694_CR120","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1172\/JCI129903","volume":"129","author":"F Deng","year":"2019","unstructured":"Deng, F., Sharma, I., Dai, Y., Yang, M. & Kanwar, Y. S. Myo-inositol oxygenase expression profile modulates pathogenic ferroptosis in the renal proximal tubule. J. Clin. Invest. 129, 5033\u20135049\u00a0(2019).","journal-title":"J. Clin. Invest."},{"key":"694_CR121","doi-asserted-by":"publisher","first-page":"102382","DOI":"10.1016\/j.redox.2022.102382","volume":"54","author":"DH Kim","year":"2022","unstructured":"Kim, D. H. et al. Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes. Redox Biol. 54, 102382 (2022).","journal-title":"Redox Biol."},{"key":"694_CR122","doi-asserted-by":"publisher","first-page":"109162","DOI":"10.1016\/j.intimp.2022.109162","volume":"112","author":"W Qiu","year":"2022","unstructured":"Qiu, W. et al. Melatonin suppresses ferroptosis via activation of the Nrf2\/HO-1 signaling pathway in the mouse model of sepsis-induced acute kidney injury. Int. Immunopharmacol. 112, 109162 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"694_CR123","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1681\/ASN.2021040460","volume":"32","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Ferroptosis promotes cyst growth in autosomal dominant polycystic kidney disease mouse models. J. Am. Soc. Nephrol. 32, 2759\u20132776 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04137-1","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death Dis. 12, 843 (2021).","journal-title":"Cell Death Dis."},{"key":"694_CR125","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000499685","volume":"44","author":"Z Ye","year":"2019","unstructured":"Ye, Z. et al. Caspase-11 mediates pyroptosis of tubular epithelial cells and septic acute kidney injury. Kidney Blood Press. Res. 44, 465\u2013478 (2019).","journal-title":"Kidney Blood Press. Res."},{"key":"694_CR126","doi-asserted-by":"publisher","first-page":"F75","DOI":"10.1152\/ajprenal.00117.2013","volume":"306","author":"JR Yang","year":"2014","unstructured":"Yang, J. R. et al. Ischemia-reperfusion induces renal tubule pyroptosis via the CHOP-caspase-11 pathway. Am. J. Physiol. Ren. Physiol. 306, F75\u2013F84 (2014).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"694_CR127","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.kint.2019.04.035","volume":"96","author":"N Miao","year":"2019","unstructured":"Miao, N. et al. The cleavage of gasdermin D by caspase-11 promotes tubular epithelial cell pyroptosis and urinary IL-18 excretion in acute kidney injury. Kidney Int. 96, 1105\u20131120\u00a0(2019).","journal-title":"Kidney Int."},{"key":"694_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05230-9","volume":"13","author":"W Tonnus","year":"2022","unstructured":"Tonnus, W. et al. Gasdermin D-deficient mice are hypersensitive to acute kidney injury. Cell Death Dis. 13, 792 (2022).","journal-title":"Cell Death Dis."},{"key":"694_CR129","doi-asserted-by":"publisher","first-page":"F96","DOI":"10.1152\/ajprenal.00351.2019","volume":"318","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Activation of GSDMD contributes to acute kidney injury induced by cisplatin. Am. J. Physiol. Ren. Physiol. 318, F96\u2013F106 (2020).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"694_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03431-2","volume":"12","author":"W Xia","year":"2021","unstructured":"Xia, W. et al. Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation. Cell Death Dis. 12, 139 (2021).","journal-title":"Cell Death Dis."},{"key":"694_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1023-x","volume":"9","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury. Cell Death Dis. 9, 983 (2018).","journal-title":"Cell Death Dis."},{"key":"694_CR132","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000524164","volume":"8","author":"D Lv","year":"2022","unstructured":"Lv, D. et al. Treatment of membranous nephropathy by disulfiram through inhibition of podocyte pyroptosis. Kidney Dis. 8, 308\u2013318 (2022).","journal-title":"Kidney Dis."},{"key":"694_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04737-5","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction. Cell Death Dis. 13, 281 (2022).","journal-title":"Cell Death Dis."},{"key":"694_CR134","doi-asserted-by":"publisher","first-page":"720877","DOI":"10.3389\/fimmu.2021.720877","volume":"12","author":"H Cao","year":"2021","unstructured":"Cao, H. et al. Novel effects of combination therapy through inhibition of caspase-1\/gasdermin D induced-pyroptosis in lupus nephritis. Front. Immunol. 12, 720877 (2021).","journal-title":"Front. Immunol."},{"key":"694_CR135","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41418-021-00755-6","volume":"28","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy. Cell Death Differ. 28, 2333\u20132350 (2021).","journal-title":"Cell Death Differ."},{"key":"694_CR136","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"694_CR137","doi-asserted-by":"publisher","first-page":"173574","DOI":"10.1016\/j.ejphar.2020.173574","volume":"888","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Ferroptosis involves in renal tubular cell death in diabetic nephropathy. Eur. J. Pharmacol. 888, 173574 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"694_CR138","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/ki.1988.205","volume":"34","author":"MS Paller","year":"1988","unstructured":"Paller, M. S. & Hedlund, B. E. Role of iron in postischemic renal injury in the rat. Kidney Int. 34, 474\u2013480 (1988).","journal-title":"Kidney Int."},{"key":"694_CR139","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1172\/JCI115942","volume":"90","author":"RA Zager","year":"1992","unstructured":"Zager, R. A. Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J. Clin. Invest. 90, 711\u2013719 (1992).","journal-title":"J. Clin. Invest."},{"key":"694_CR140","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41420-022-00931-8","volume":"8","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Ferroptosis, a new target for treatment of renal injury and fibrosis in a 5\/6 nephrectomy-induced CKD rat model. Cell Death Discov. 8, 127 (2022).","journal-title":"Cell Death Discov."},{"key":"694_CR141","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00240-003-0329-y","volume":"31","author":"MC Avunduk","year":"2003","unstructured":"Avunduk, M. C., Yurdakul, T., Erdemli, E. & Yavuz, A. Prevention of renal damage by alpha tocopherol in ischemia and reperfusion models of rats. Urol. Res. 31, 280\u2013285 (2003).","journal-title":"Urol. Res."},{"key":"694_CR142","doi-asserted-by":"publisher","first-page":"15248","DOI":"10.1007\/s11356-019-04801-2","volume":"26","author":"MM Abdel-Daim","year":"2019","unstructured":"Abdel-Daim, M. M. et al. The ameliorative effects of ceftriaxone and vitamin E against cisplatin-induced nephrotoxicity. Environ. Sci. Pollut. Res. Int. 26, 15248\u201315254 (2019).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"694_CR143","doi-asserted-by":"publisher","first-page":"10286","DOI":"10.1096\/fj.201902544RR","volume":"34","author":"Y Shi","year":"2020","unstructured":"Shi, Y. et al. RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury. FASEB J. 34, 10286\u201310298 (2020).","journal-title":"FASEB J."},{"key":"694_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67054-x","volume":"10","author":"Y Shi","year":"2020","unstructured":"Shi, Y. et al. RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy. Sci. Rep. 10, 10458 (2020).","journal-title":"Sci. Rep."},{"key":"694_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274116","volume":"17","author":"SG Piao","year":"2022","unstructured":"Piao, S. G. et al. Inhibition of RIP1-RIP3-mediated necroptosis attenuates renal fibrosis via Wnt3\u03b1\/\u03b2-catenin\/GSK-3\u03b2 signaling in unilateral ureteral obstruction. PLoS ONE 17, e0274116 (2022).","journal-title":"PLoS ONE"},{"key":"694_CR146","doi-asserted-by":"publisher","first-page":"109262","DOI":"10.1016\/j.intimp.2022.109262","volume":"112","author":"CH Xu","year":"2022","unstructured":"Xu, C. H. et al. RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation. Int. Immunopharmacol. 112, 109262 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"694_CR147","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1042\/CS20190599","volume":"133","author":"JN Wang","year":"2019","unstructured":"Wang, J. N. et al. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress. Clin. Sci. 133, 1609\u20131627 (2019).","journal-title":"Clin. Sci."},{"key":"694_CR148","doi-asserted-by":"publisher","first-page":"6636621","DOI":"10.1155\/2021\/6636621","volume":"2021","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. Caspase-1-inhibitor AC-YVAD-CMK inhibits pyroptosis and ameliorates acute kidney injury in a model of sepsis. Biomed. Res. Int. 2021, 6636621 (2021).","journal-title":"Biomed. Res. Int."},{"key":"694_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03458-5","volume":"12","author":"X Shen","year":"2021","unstructured":"Shen, X., Wang, H., Weng, C., Jiang, H. & Chen, J. Caspase 3\/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity. Cell Death Dis. 12, 186 (2021).","journal-title":"Cell Death Dis."},{"key":"694_CR150","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.nefro.2017.04.004","volume":"38","author":"D Martin-Sanchez","year":"2018","unstructured":"Martin-Sanchez, D. et al. Targeting of regulated necrosis in kidney disease. Nefrologia 38, 125\u2013135 (2018).","journal-title":"Nefrologia"},{"key":"694_CR151","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41418-020-00690-y","volume":"28","author":"T Riebeling","year":"2021","unstructured":"Riebeling, T. et al. Primidone blocks RIPK1-driven cell death and inflammation. Cell Death Differ. 28, 1610\u20131626 (2021).","journal-title":"Cell Death Differ."},{"key":"694_CR152","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136329","volume":"131","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. The key role of NLRP3 and STING in APOL1-associated podocytopathy. J. Clin. Invest. 131, e136329\u00a0(2021).","journal-title":"J. Clin. Invest."},{"key":"694_CR153","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00710559","volume":"406","author":"TS Olsen","year":"1985","unstructured":"Olsen, T. S., Olsen, H. S. & Hansen, H. E. Tubular ultrastructure in acute renal failure in man: epithelial necrosis and regeneration. Virchows Arch. A Pathol. Anat. Histopathol. 406, 75\u201389 (1985).","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"694_CR154","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.kint.2019.07.002","volume":"96","author":"W Tonnus","year":"2019","unstructured":"Tonnus, W. & Linkermann, A. Gasdermin D and pyroptosis in acute kidney injury. Kidney Int. 96, 1061\u20131063 (2019).","journal-title":"Kidney Int."},{"key":"694_CR155","first-page":"831","volume":"140","author":"M Schumer","year":"1992","unstructured":"Schumer, M. et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am. J. Pathol. 140, 831\u2013838 (1992).","journal-title":"Am. J. Pathol."},{"key":"694_CR156","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ki.2013.68","volume":"84","author":"Q Wei","year":"2013","unstructured":"Wei, Q., Dong, G., Chen, J. K., Ramesh, G. & Dong, Z. Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule-specific knockout mouse models. Kidney Int. 84, 138\u2013148 (2013).","journal-title":"Kidney Int."},{"key":"694_CR157","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1172\/JCI6974","volume":"104","author":"MA Daemen","year":"1999","unstructured":"Daemen, M. A. et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J. Clin. Invest. 104, 541\u2013549 (1999).","journal-title":"J. Clin. Invest."},{"key":"694_CR158","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/ALN.0000000000002104","volume":"128","author":"P Ederoth","year":"2018","unstructured":"Ederoth, P. et al. Cyclosporine before coronary artery bypass grafting does not prevent postoperative decreases in renal function: a randomized clinical trial. Anesthesiology 128, 710\u2013717 (2018).","journal-title":"Anesthesiology"},{"key":"694_CR159","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/cdd.2016.46","volume":"23","author":"K Newton","year":"2016","unstructured":"Newton, K. et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 23, 1565\u20131576 (2016).","journal-title":"Cell Death Differ."},{"key":"694_CR160","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fcell.2019.00019","volume":"7","author":"C Moerke","year":"2019","unstructured":"Moerke, C., Bleibaum, F., Kunzendorf, U. & Krautwald, S. Combined knockout of RIPK3 and MLKL reveals unexpected outcome in tissue injury and inflammation. Front. Cell Dev. Biol. 7, 19 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"694_CR161","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","volume":"19","author":"C Tang","year":"2023","unstructured":"Tang, C., Livingston, M. J., Safirstein, R. & Dong, Z. Cisplatin nephrotoxicity: new insights and therapeutic implications. Nat. Rev. Nephrol. 19, 53\u201372 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"694_CR162","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","volume":"23","author":"I Arany","year":"2003","unstructured":"Arany, I. & Safirstein, R. L. Cisplatin nephrotoxicity. Semin. Nephrol. 23, 460\u2013464 (2003).","journal-title":"Semin. Nephrol."},{"key":"694_CR163","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/toxsci\/kfr098","volume":"122","author":"SM Sancho-Mart\u00ednez","year":"2011","unstructured":"Sancho-Mart\u00ednez, S. M., Piedrafita, F. J., Cannata-And\u00eda, J. B., L\u00f3pez-Novoa, J. M. & L\u00f3pez-Hern\u00e1ndez, F. J. Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis. Toxicol. Sci. 122, 73\u201385 (2011).","journal-title":"Toxicol. Sci."},{"key":"694_CR164","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10495-015-1190-5","volume":"21","author":"VR Trist\u00e3o","year":"2016","unstructured":"Trist\u00e3o, V. R. et al. Synergistic effect of apoptosis and necroptosis inhibitors in cisplatin-induced nephrotoxicity. Apoptosis 21, 51\u201359 (2016).","journal-title":"Apoptosis"},{"key":"694_CR165","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1161\/STROKEAHA.116.015609","volume":"48","author":"M Zille","year":"2017","unstructured":"Zille, M. et al. Neuronal death after hemorrhagic stroke in vitro and in vivo shares features of ferroptosis and necroptosis. Stroke 48, 1033\u20131043 (2017).","journal-title":"Stroke"},{"key":"694_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28718-6","volume":"13","author":"S Van Coillie","year":"2022","unstructured":"Van Coillie, S. et al. Targeting ferroptosis protects against experimental (multi)organ dysfunction and death. Nat. Commun. 13, 1046 (2022).","journal-title":"Nat. Commun."},{"key":"694_CR167","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med. 383, 2255\u20132273 (2020).","journal-title":"N. Engl. J. Med."},{"key":"694_CR168","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2036236","volume":"384","author":"M Gaestel","year":"2021","unstructured":"Gaestel, M., Nebreda, A. R. & Yaffe, M. B. Cytokine storm. N. Engl. J. Med. 384, e59 (2021).","journal-title":"N. Engl. J. Med."},{"key":"694_CR169","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1038\/s41418-020-0524-1","volume":"27","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis. Cell Death Differ. 27, 2568\u20132585 (2020).","journal-title":"Cell Death Differ."},{"key":"694_CR170","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu, J. J. et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat. Immunol. 21, 736\u2013745 (2020).","journal-title":"Nat. Immunol."},{"key":"694_CR171","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/j.1523-1755.2005.00566.x","volume":"68","author":"MS Schepers","year":"2005","unstructured":"Schepers, M. S., van Ballegooijen, E. S., Bangma, C. H. & Verkoelen, C. F. Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells. Kidney Int. 68, 1543\u20131553 (2005).","journal-title":"Kidney Int."},{"key":"694_CR172","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4049\/jimmunol.1900228","volume":"203","author":"M Rashidi","year":"2019","unstructured":"Rashidi, M. et al. The pyroptotic cell death effector gasdermin D is activated by gout-associated uric acid crystals but is dispensable for cell death and IL-1\u03b2 release. J. Immunol. 203, 736\u2013748 (2019).","journal-title":"J. Immunol."},{"key":"694_CR173","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.kint.2017.09.022","volume":"93","author":"HJ Anders","year":"2018","unstructured":"Anders, H. J. et al. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury. Kidney Int. 93, 656\u2013669 (2018).","journal-title":"Kidney Int."},{"key":"694_CR174","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.kint.2016.03.035","volume":"90","author":"I Ludwig-Portugall","year":"2016","unstructured":"Ludwig-Portugall, I. et al. An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. Kidney Int. 90, 525\u2013539 (2016).","journal-title":"Kidney Int."},{"key":"694_CR175","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/path.5882","volume":"257","author":"L Mart\u00edn-Saiz","year":"2022","unstructured":"Mart\u00edn-Saiz, L. et al. Ferrostatin-1 modulates dysregulated kidney lipids in acute kidney injury. J. Pathol. 257, 285\u2013299\u00a0(2022).","journal-title":"J. Pathol."},{"key":"694_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31772-9","volume":"13","author":"MS Balzer","year":"2022","unstructured":"Balzer, M. S. et al. Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regeneration. Nat. Commun. 13, 4018 (2022).","journal-title":"Nat. Commun."},{"key":"694_CR177","doi-asserted-by":"publisher","first-page":"754134","DOI":"10.3389\/fcell.2021.754134","volume":"9","author":"M Wu","year":"2021","unstructured":"Wu, M. et al. Gasdermin E deletion attenuates ureteral obstruction- and 5\/6 nephrectomy-induced renal fibrosis and kidney dysfunction. Front. Cell Dev. Biol. 9, 754134 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"694_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05138-4","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. GSDMD-dependent neutrophil extracellular traps promote macrophage-to-myofibroblast transition and renal fibrosis in obstructive nephropathy. Cell Death Dis. 13, 693 (2022).","journal-title":"Cell Death Dis."},{"key":"694_CR179","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841\u2013845 (2010).","journal-title":"Science"},{"key":"694_CR180","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1681\/ASN.2007050577","volume":"19","author":"AB Sanz","year":"2008","unstructured":"Sanz, A. B. et al. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J. Am. Soc. Nephrol. 19, 695\u2013703 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR181","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.bbadis.2013.05.032","volume":"1832","author":"AC Ucero","year":"2013","unstructured":"Ucero, A. C. et al. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast. Biochim. Biophys. Acta 1832, 1744\u20131755\u00a0(2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"694_CR182","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1111\/j.1582-4934.2009.00766.x","volume":"13","author":"AB Sanz","year":"2009","unstructured":"Sanz, A. B. et al. Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia. J. Cell Mol. Med. 13, 3329\u20133342 (2009).","journal-title":"J. Cell Mol. Med."},{"key":"694_CR183","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2020071094","volume":"32","author":"A Cordido","year":"2021","unstructured":"Cordido, A. et al. TWEAK signaling pathway blockade slows cyst growth and disease progression in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 32, 1913\u20131932 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR184","doi-asserted-by":"publisher","first-page":"F221","DOI":"10.1152\/ajprenal.00104.2019","volume":"317","author":"B Yang","year":"2019","unstructured":"Yang, B. et al. Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis. Am. J. Physiol. Ren. Physiol. 317, F221\u2013F228 (2019).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"694_CR185","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/art.41444","volume":"72","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Effects of gasdermin D in modulating murine lupus and its associated organ damage. Arthritis Rheumatol. 72, 2118\u20132129 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"694_CR186","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41420-022-01167-2","volume":"8","author":"L Zhuang","year":"2022","unstructured":"Zhuang, L. et al. Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis. Cell Death Discov. 8, 379 (2022).","journal-title":"Cell Death Discov."},{"key":"694_CR187","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41420-022-00848-2","volume":"8","author":"G Luo","year":"2022","unstructured":"Luo, G. et al. Blocking GSDME-mediated pyroptosis in renal tubular epithelial cells alleviates disease activity in lupus mice. Cell Death Discov. 8, 113 (2022).","journal-title":"Cell Death Discov."},{"key":"694_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0394-3","volume":"9","author":"A von M\u00e4ssenhausen","year":"2018","unstructured":"von M\u00e4ssenhausen, A. et al. Phenytoin inhibits necroptosis. Cell Death Dis. 9, 359 (2018).","journal-title":"Cell Death Dis."},{"key":"694_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03118-0","volume":"11","author":"B Wiernicki","year":"2020","unstructured":"Wiernicki, B. et al. Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis. Cell Death Dis. 11, 922 (2020).","journal-title":"Cell Death Dis."},{"key":"694_CR190","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.yjmcc.2010.05.011","volume":"49","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. 4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. J. Mol. Cell Cardiol. 49, 576\u2013586 (2010).","journal-title":"J. Mol. Cell Cardiol."},{"key":"694_CR191","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2012.199","volume":"82","author":"B Humanes","year":"2012","unstructured":"Humanes, B. et al. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats. Kidney Int. 82, 652\u2013663 (2012).","journal-title":"Kidney Int."},{"key":"694_CR192","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/antiox9090821","volume":"9","author":"JC Jado","year":"2020","unstructured":"Jado, J. C. et al. Nephroprotective effect of cilastatin against gentamicin-induced renal injury in vitro and in vivo without altering its bactericidal efficiency. Antioxidants 9, 821\u00a0(2020).","journal-title":"Antioxidants"},{"key":"694_CR193","doi-asserted-by":"publisher","first-page":"704382","DOI":"10.1155\/2015\/704382","volume":"2015","author":"B Humanes","year":"2015","unstructured":"Humanes, B. et al. Protective effects of cilastatin against vancomycin-induced nephrotoxicity. Biomed. Res. Int. 2015, 704382 (2015).","journal-title":"Biomed. Res. Int."},{"key":"694_CR194","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1681\/ASN.2020030263","volume":"32","author":"K Matsushita","year":"2021","unstructured":"Matsushita, K. et al. Cilastatin ameliorates rhabdomyolysis-induced AKI in mice. J. Am. Soc. Nephrol. 32, 2579\u20132594 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR195","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.3390\/ijms21103583","volume":"21","author":"YA Hong","year":"2020","unstructured":"Hong, Y. A. et al. Cilastatin preconditioning attenuates renal Ischemia-reperfusion injury via hypoxia inducible factor-1\u03b1 activation. Int. J. Mol. Sci. 21, 3583\u00a0(2020).","journal-title":"Int. J. Mol. Sci."},{"key":"694_CR196","doi-asserted-by":"publisher","first-page":"eabl8920","DOI":"10.1126\/sciadv.abl8920","volume":"8","author":"A von M\u00e4ssenhausen","year":"2022","unstructured":"von M\u00e4ssenhausen, A. et al. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. Sci. Adv. 8, eabl8920 (2022).","journal-title":"Sci. Adv."},{"key":"694_CR197","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1681\/ASN.2016060606","volume":"28","author":"Y Hori","year":"2017","unstructured":"Hori, Y. et al. Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. J. Am. Soc. Nephrol. 28, 1783\u20131791 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR198","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.cell.2019.07.017","volume":"178","author":"SR Choudhury","year":"2019","unstructured":"Choudhury, S. R. et al. Dipeptidase-1 is an adhesion receptor for neutrophil recruitment in lungs and liver. Cell 178, 1205\u20131221.e17 (2019).","journal-title":"Cell"},{"key":"694_CR199","doi-asserted-by":"publisher","first-page":"eabm0142","DOI":"10.1126\/sciadv.abm0142","volume":"8","author":"A Lau","year":"2022","unstructured":"Lau, A. et al. Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury. Sci. Adv. 8, eabm0142 (2022).","journal-title":"Sci. Adv."},{"key":"694_CR200","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1093\/ndt\/gfh397","volume":"19","author":"M P\u00e9rez","year":"2004","unstructured":"P\u00e9rez, M. et al. Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. Nephrol. Dial. Transpl. 19, 2445\u20132455 (2004).","journal-title":"Nephrol. Dial. Transpl."},{"key":"694_CR201","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1194\/jlr.M080465","volume":"59","author":"E Moreno-Gordaliza","year":"2018","unstructured":"Moreno-Gordaliza, E. et al. Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity. J. Lipid Res. 59, 1561\u20131574 (2018).","journal-title":"J. Lipid Res."},{"key":"694_CR202","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1185\/030079906X167633","volume":"23","author":"A Tejedor","year":"2007","unstructured":"Tejedor, A. et al. Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence. Curr. Med. Res. Opin. 23, 505\u2013513 (2007).","journal-title":"Curr. Med. Res. Opin."},{"key":"694_CR203","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/ckj\/sfaa193","volume":"13","author":"M Gonz\u00e1lez-Nicol\u00e1s","year":"2020","unstructured":"Gonz\u00e1lez-Nicol\u00e1s, M., Gonz\u00e1lez-Guerrero, C., P\u00e9rez-Fern\u00e1ndez, V. A. & L\u00e1zaro, A. Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm. Clin. Kidney J. 13, 903\u2013905 (2020).","journal-title":"Clin. Kidney J."},{"key":"694_CR204","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima, E. et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature 608, 778\u2013783 (2022).","journal-title":"Nature"},{"key":"694_CR205","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00018-022-04416-w","volume":"79","author":"B Kolbrink","year":"2022","unstructured":"Kolbrink, B. et al. Vitamin K1 inhibits ferroptosis and counteracts a detrimental effect of phenprocoumon in experimental acute kidney injury. Cell Mol. Life Sci. 79, 387 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"694_CR206","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1053\/j.ajkd.2009.04.024","volume":"54","author":"SV Brodsky","year":"2009","unstructured":"Brodsky, S. V. et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am. J. Kidney Dis. 54, 1121\u20131126 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"694_CR207","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ki.2011.44","volume":"80","author":"SV Brodsky","year":"2011","unstructured":"Brodsky, S. V. et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int. 80, 181\u2013189 (2011).","journal-title":"Kidney Int."},{"key":"694_CR208","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2215\/CJN.01970211","volume":"7","author":"JA Moreno","year":"2012","unstructured":"Moreno, J. A. et al. AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin. J. Am. Soc. Nephrol. 7, 175\u2013184 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"694_CR209","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1093\/ndt\/gfq493","volume":"25","author":"C Mart\u00edn Cleary","year":"2010","unstructured":"Mart\u00edn Cleary, C. et al. Glomerular haematuria, renal interstitial haemorrhage and acute kidney injury. Nephrol. Dial. Transpl. 25, 4103\u20134106 (2010).","journal-title":"Nephrol. Dial. Transpl."},{"key":"694_CR210","doi-asserted-by":"publisher","first-page":"c42","DOI":"10.1159\/000342385","volume":"121","author":"E Guti\u00e9rrez","year":"2012","unstructured":"Guti\u00e9rrez, E. et al. Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin. Pract. 121, c42\u2013c53 (2012).","journal-title":"Nephron Clin. Pract."},{"key":"694_CR211","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/ckj\/sfac109","volume":"15","author":"AO G\u00e9rard","year":"2022","unstructured":"G\u00e9rard, A. O. et al. Risk factors associated with immune checkpoint inhibitor-induced acute kidney injury compared with other immune-related adverse events: a case-control study. Clin. Kidney J. 15, 1881\u20131887 (2022).","journal-title":"Clin. Kidney J."},{"key":"694_CR212","doi-asserted-by":"publisher","first-page":"635.e1","DOI":"10.1016\/j.amjmed.2015.11.032","volume":"129","author":"TJ Poterucha","year":"2016","unstructured":"Poterucha, T. J. & Goldhaber, S. Z. Warfarin and vascular calcification. Am. J. Med. 129, 635.e1\u2013635.e4 (2016).","journal-title":"Am. J. Med."},{"key":"694_CR213","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ebiom.2016.01.011","volume":"4","author":"FF Wei","year":"2016","unstructured":"Wei, F. F. et al. Vitamin K dependent protection of renal function in multi-ethnic population studies. EBioMedicine 4, 162\u2013169 (2016).","journal-title":"EBioMedicine"},{"key":"694_CR214","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1016\/j.jacc.2017.09.1087","volume":"70","author":"X Yao","year":"2017","unstructured":"Yao, X. et al. Renal outcomes in anticoagulated patients with atrial fibrillation. J. Am. Coll. Cardiol. 70, 2621\u20132632 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"694_CR215","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1053\/j.ajkd.2019.07.012","volume":"75","author":"Z Al-Aly","year":"2020","unstructured":"Al-Aly, Z., Maddukuri, G. & Xie, Y. Proton pump inhibitors and the kidney: implications of current evidence for clinical practice and when and how to deprescribe. Am. J. Kidney Dis. 75, 497\u2013507 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"694_CR216","doi-asserted-by":"publisher","first-page":"101464","DOI":"10.1016\/j.redox.2020.101464","volume":"32","author":"M Fontecha-Barriuso","year":"2020","unstructured":"Fontecha-Barriuso, M. et al. Molecular pathways driving omeprazole nephrotoxicity. Redox Biol. 32, 101464 (2020).","journal-title":"Redox Biol."},{"key":"694_CR217","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1111\/jcmm.16302","volume":"25","author":"L Ye","year":"2021","unstructured":"Ye, L. et al. Lansoprazole promotes cisplatin-induced acute kidney injury via enhancing tubular necroptosis. J. Cell Mol. Med. 25, 2703\u20132713 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"694_CR218","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1681\/ASN.2019060570","volume":"31","author":"E Mishima","year":"2020","unstructured":"Mishima, E. et al. Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers. J. Am. Soc. Nephrol. 31, 280\u2013296 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR219","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1373\/clinchem.2017.272377","volume":"63","author":"JE Raizman","year":"2017","unstructured":"Raizman, J. E., Colbourne, P. D., LeGatt, D. F., Chow, D. & Rudolph, L. Glistening urine sample from a patient with delirium. Clin. Chem. 63, 1306\u20131307 (2017).","journal-title":"Clin. Chem."},{"key":"694_CR220","first-page":"1","volume":"476","author":"National Toxicology Program.","year":"2000","unstructured":"National Toxicology Program.NTP toxicology and carcinogenesis studies of primidone (CAS no. 125-33-7) in F344\/N rats and B6C3F1 mice (feed studies). Natl Toxicol. Program. Tech. Rep. Ser. 476, 1\u2013290 (2000).","journal-title":"Natl Toxicol. Program. Tech. Rep. Ser."},{"key":"694_CR221","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.kint.2022.07.024","volume":"102","author":"X Fan","year":"2022","unstructured":"Fan, X. et al. Hemopexin accumulates in kidneys and worsens acute kidney injury by causing hemoglobin deposition and exacerbation of iron toxicity in proximal tubules. Kidney Int. 102, 1320\u20131330 (2022).","journal-title":"Kidney Int."},{"key":"694_CR222","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nrneph.2014.121","volume":"10","author":"JD D\u00edaz-Garc\u00eda","year":"2014","unstructured":"D\u00edaz-Garc\u00eda, J. D. et al. Deferasirox nephrotoxicity \u2013 the knowns and unknowns. Nat. Rev. Nephrol. 10, 574\u2013586 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"694_CR223","doi-asserted-by":"publisher","DOI":"10.1038\/srep41510","volume":"7","author":"D Martin-Sanchez","year":"2017","unstructured":"Martin-Sanchez, D. et al. Deferasirox-induced iron depletion promotes BclxL downregulation and death of proximal tubular cells. Sci. Rep. 7, 41510 (2017).","journal-title":"Sci. Rep."},{"key":"694_CR224","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ndt\/gfaa348","volume":"36","author":"RA Zager","year":"2021","unstructured":"Zager, R. A., Johnson, A. C. M. & Therapeutics, R. Iron sucrose (\u2018RBT-3\u2019) activates the hepatic and renal HAMP1 gene, evoking renal hepcidin loading and resistance to cisplatin nephrotoxicity. Nephrol. Dial. Transpl. 36, 465\u2013474 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"694_CR225","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1681\/ASN.2014101037","volume":"26","author":"Y Scindia","year":"2015","unstructured":"Scindia, Y. et al. Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis. J. Am. Soc. Nephrol. 26, 2800\u20132814 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"694_CR226","doi-asserted-by":"publisher","first-page":"115072","DOI":"10.1016\/j.ejmech.2022.115072","volume":"247","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect. Eur. J. Med. Chem. 247, 115072 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"694_CR227","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09019-w","volume":"12","author":"C Delehouz\u00e9","year":"2022","unstructured":"Delehouz\u00e9, C. et al. Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death. Sci. Rep. 12, 5118 (2022).","journal-title":"Sci. Rep."},{"key":"694_CR228","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1021\/acsmedchemlett.9b00142","volume":"10","author":"K Dodo","year":"2019","unstructured":"Dodo, K. et al. Development of a water-soluble indolylmaleimide derivative IM-93 showing dual inhibition of ferroptosis and NETosis. ACS Med. Chem. Lett. 10, 1272\u20131278 (2019).","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00694-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:49:02Z","timestamp":1733939342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00694-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":228,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["694"],"URL":"https:\/\/doi.org\/10.1038\/s41581-023-00694-0","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"16 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.O. has received grants from Sanofi and consultancy, speaker fees or travel support from Advicciene, Astellas, AstraZeneca, Amicus, Amgen, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Menarini, Kyowa Kirin, Alexion, Idorsia, Chiesi, Otsuka, Novo-Nordisk and Vifor Fresenius Medical Care Renal Pharma, and is\u00a0the Director of the Catedra Mundipharma-UAM for diabetic kidney disease and the Catedra Astrazeneca-UAM for chronic kidney disease and electrolytes. A.O. also has stock in Telara Farma. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}